He underwent stereotactic biopsy and was diagnosed with IDH-wild-type, MGMT non-methylated glioma CNS WHO grade 3 (suggestive of PAA24) and was treated with radiochemotherapy with adjuvant temozolomide (TMZ). This evidence concerns the gene IDH2 and central nervous system cancer.